Skip to main content
FIZE MedicalNews

Understanding and Mitigating Acute Kidney Injury (AKI) After Cardiac Surgery

By January 20, 2024October 31st, 2024No Comments

Acute kidney injury (AKI) is a common postoperative complication that occurs in 20 to 30% of cardiac surgical patients (Sreekanth 2023). Postoperative AKI is associated with mortality after surgery, which increases to 50-60% when renal replacement therapy is required ( Lee 2021 and Sreekanth). While AKI may occur after various surgical procedures, it is more prevalent and often more severe in the context of cardiac surgeries.

Cardiac surgery-associated AKI is influenced by a combination of factors inherent to both the surgical procedure and the underlying cardiac condition. Cardiac surgeries include complex procedures such as coronary artery bypass grafting (CABG), valve replacements, and congenital defect corrections, to name a few. These surgeries often require the use of cardiopulmonary bypass machines, which can inadvertently affect kidney function. Maintaining appropriate perfusion pressure and cardiac output during procedures utilizing cardiopulmonary bypass machines is critical for prevention of AKI.

The causes of AKI after cardiac surgery are complex and multifactorial. Many of the factors involved with an increased AKI risk are not modifiable, such as advanced age, diabetes, hypertension, hyperlipidemia, peripheral vascular disease, and preexisting chronic kidney disease . The effects of other risk factors can be mitigated, such as those related to the surgical and anesthetic management. Examples include: use and management of cardiopulmonary bypass machines, aortic cross-clamping, blood transfusion, vasopressors, nephrotoxic drugs, and finally, prevention and appropriate correction of ischemia-reperfusion injury. These risk factors potentially alter the renal perfusion, inducing oxidative stress and inflammation, damaging the renal tubules and glomeruli, and activating the coagulation and complement systems; all mechanisms that can lead to development of AKI .

Early detection of AKI is paramount to improving patient outcomes. Real-time and continuous urine output monitoring, in addition to advancements in electronic health records and machine learning algorithms, have enabled healthcare professionals to better predict AKI risk by considering various patient-specific factors.

In conclusion, while various biomarkers and diagnostic methods contribute to the understanding of cardiac surgery-associated AKI, the most accessible and reliable tool for the detection of AKI is consistent and accurate urine output monitoring. As medical technology continues to advance, incorporating this fundamental, yet effective approach into routine clinical practice can make a significant difference in the lives of patients undergoing cardiac surgery, ensuring that AKI is promptly detected and managed to enhance recovery prospects and reduce mortality rates.

 

References:

Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., Daley, J. (1998). Independent association between acute renal failure and mortality following cardiac surgery. American Journal of Medicine, 104(4), 343-348.

Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Muñoz A, Alvarez P, Hernandez C. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. International journal of nephrology and renovascular disease. 2019 Jul 2:153-66.

O’Neal JB, Shaw AD, Billings FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Critical care. 2016 Dec;20:1-9.

KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements, 2(1), 1-138. 2012.

Hobson, C. E., Yavas, S., Segal, M. S., Schold, J. D., Tribble, C. G., Layon, A. J., Bihorac, A. (2009). Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation, 119(18), 2444-2453.

Haase, M., Bellomo, R., Devarajan, P., Schlattmann, P., Haase-Fielitz, A. (2011). Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases, 58(3), 417-425.

Ostermann, M., & Joannidis, M. (2016). Acute kidney injury 2016: diagnosis and diagnostic workup. Critical Care, 20(1), 299.

Rapha Capital Management, LLC is providing this website for informational purposes only. Nothing on this website is intended to constitute, or should be deemed to be, financial advisory, legal, tax, accounting or other professional advice to you or any other party; be an opinion of the appropriateness or suitability of any investment; or constitute an offer to sell or solicitation of an offer to buy any security or investment. This website and its content (collectively, “Content”) is intended for general informational purposes only and should not be acted upon without first obtaining financial advisory, legal, tax, accounting or other professional advice from your consultant or other professional with respect to your own personal investment objectives, financial circumstances and needs. Nothing on the Site shall be considered a recommendation or solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Any investment decisions you may make on the basis of any information found on this web site is your sole responsibility. Prior to making any investment or hiring any investment manager you should consult with a professional financial advisor, legal and tax advisor to assist in due diligence as may be appropriate and determining the appropriateness of the risk associated with a particular investment. In no event shall Rapha Capital Management, LLC be responsible or liable for the correctness of any such material or for any damage or lost opportunities resulting from use of these data.

Powered by